SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-019402
Filing Date
2023-05-30
Accepted
2023-05-30 09:00:13
Documents
15
Period of Report
2023-05-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44066
2 ex99-1.htm EX-99.1 16637
3 ex99-1_001.jpg GRAPHIC 22585
  Complete submission text file 0001493152-23-019402.txt   327660

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bfri-20230530.xsd EX-101.SCH 4288
5 XBRL DEFINITION FILE bfri-20230530_def.xml EX-101.DEF 27600
6 XBRL LABEL FILE bfri-20230530_lab.xml EX-101.LAB 38253
7 XBRL PRESENTATION FILE bfri-20230530_pre.xml EX-101.PRE 26217
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6875
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 23971643
SIC: 2834 Pharmaceutical Preparations